Literature DB >> 19212911

Microalbuminuria--a biomarker of renal microvascular disease.

Narisa Futrakul1, Vitaya Sridama, Prasit Futrakul.   

Abstract

Microalbuminuria (amount greater than 30-300 mg/day) reflects an abnormal glomerular capillary permeability to protein. It is usually dependent upon three mechanisms. First, loss of negatively charged surface of the glomerular capillary wall secondary to circulating toxic substances injury-namely, oxidative stress and proinflammatory cytokines-allows the albumin with negatively charged surface to freely escape into the urine. Second, intraglomerular hypertension and hemodynamic maladjustment secondary to glomerular endothelial dysfunction increases filtration pressure and enhances sized selective proteinuria leakage. Third, podocyte injury leads to a vicious cycle of hemodynamic maladjustment and endothelial and podocyte injuries. All three of these mechanisms induce glomerular endothelial injury and microalbuminuria, which reflects renal microvascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19212911     DOI: 10.1080/08860220802595948

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  23 in total

1.  Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes.

Authors:  R M Bruno; E Daghini; L Landini; D Versari; A Salvati; E Santini; I Di Paco; A Magagna; S Taddei; L Ghiadoni; A Solini
Journal:  Diabetologia       Date:  2011-04-16       Impact factor: 10.122

2.  Sleep and CKD in Chinese Adults: A Cross-Sectional Study.

Authors:  Junjuan Li; Zhe Huang; Jinhong Hou; Amy M Sawyer; Zhijun Wu; Jianfang Cai; Gary Curhan; Shouling Wu; Xiang Gao
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-07       Impact factor: 8.237

3.  Association of Blood Pressure-Related Increase in Vascular Stiffness on Other Measures of Target Organ Damage in Youth.

Authors:  Jessica E Haley; Shalayna A Woodly; Stephen R Daniels; Bonita Falkner; Michael A Ferguson; Joseph T Flynn; Coral D Hanevold; Stephen R Hooper; Julie R Ingelfinger; Philip R Khoury; Marc B Lande; Lisa J Martin; Kevin E Meyers; Mark Mitsnefes; Richard C Becker; Bernard A Rosner; Joshua Samuels; Andrew H Tran; Elaine M Urbina
Journal:  Hypertension       Date:  2022-06-28       Impact factor: 9.897

4.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

5.  Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index.

Authors:  Sílvia Juliane Piva; Etiane Tatsch; José Antonio Mainardi De Carvalho; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Maria Beatriz Moretto; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

6.  Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism.

Authors:  Yu-Hsin Lien; Tsai-Yuan Hsiang; Hui-Pi Huang
Journal:  Acta Vet Scand       Date:  2010-11-12       Impact factor: 1.695

7.  Potential renovascular hypertension, space missions, and the role of magnesium.

Authors:  William J Rowe
Journal:  Int J Nephrol Renovasc Dis       Date:  2009-11-19

8.  Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.

Authors:  Anna Solini; Giuseppe Penno; Enzo Bonora; Cecilia Fondelli; Emanuela Orsi; Maura Arosio; Roberto Trevisan; Monica Vedovato; Mauro Cignarelli; Francesco Andreozzi; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetes Care       Date:  2011-11-28       Impact factor: 19.112

9.  Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents.

Authors:  Jing He; Yuqiu Lu; Hong Xia; Yaojun Liang; Xiao Wang; Wenduona Bao; Shifeng Yun; Yuting Ye; Chunxia Zheng; Zhihong Liu; Shaolin Shi
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

10.  Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.

Authors:  Jasmine D Kerr; Rachel M Holden; Alexander R Morton; Robert L Nolan; Wilma M Hopman; Cynthia M Pruss; Jocelyn S Garland
Journal:  BMC Nephrol       Date:  2013-01-26       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.